Medpace director exercises 28 RSUs into shares
Medpace Holdings director Cornelius P. McCarthy III exercised restricted stock units into common shares.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Medpace Holdings director Cornelius P. McCarthy III exercised restricted stock units into common shares. He acquired 28 shares of Medpace common stock through the conversion of restricted stock units, bringing his direct common stock holdings to 10,352 shares. Following this transaction, he continues to hold 56 restricted stock units that each represent a contingent right to receive one share of Medpace common stock upon future vesting.
Insider Trade Summary
28 shares exercised/converted
Exercise
2 txns
Insider
McCarthy Cornelius P. III
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 28 | $0.00 | $0.00 |
| Exercise | Common Stock | 28 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 56 contracts (Direct);
Common Stock — 10,352 shares (Direct)
Holdings Before and After:
Restricted Stock Unit, 84 to 56 contracts (Direct);
Common Stock, 10,324 to 10,352 shares (Direct)
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
- F2. On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
Key Figures
Common shares acquired: 28 shares
Common shares held after: 10,352 shares
RSUs converted: 28 restricted stock units
+2 more
5 metrics
Common shares acquired
28 shares
Common Stock acquired via RSU exercise on June 30, 2026
Common shares held after
10,352 shares
Direct Medpace common stock holdings following transaction
RSUs converted
28 restricted stock units
Derivative transaction converting RSUs into common stock
RSUs remaining
56 restricted stock units
Outstanding RSUs after June 30, 2026 transaction
Original RSU grant
113 restricted stock units
Granted November 28, 2025, vesting in four installments in 2026
Key Terms
Restricted Stock Unit, derivative security, contingent right
3 terms
Restricted Stock Unit financial
"The filing reports transactions in a security titled "Restricted Stock Unit" linked to common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
derivative security financial
"Transaction code M is described as "Exercise or conversion of derivative security.""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of MEDP common stock."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Medpace (MEDP) director Cornelius P. McCarthy III report?
Director Cornelius P. McCarthy III exercised restricted stock units into Medpace common shares. He acquired 28 common shares through a derivative exercise, increasing his direct common stock holdings while retaining additional unvested restricted stock units.
What happened to the restricted stock units in the Medpace (MEDP) Form 4 filing?
The filing shows 28 restricted stock units converted into 28 Medpace common shares. After this derivative exercise, 56 restricted stock units remain outstanding, each representing a contingent right to receive one share of Medpace common stock upon vesting.
Was the Medpace (MEDP) insider transaction a market purchase or sale?
The transaction was not an open-market buy or sell. It was an exercise of restricted stock units into common stock, reported with transaction code M, which denotes the exercise or conversion of a derivative security rather than a market trade.
What do the Medpace (MEDP) restricted stock unit footnotes explain in this Form 4?
The footnotes explain that each restricted stock unit represents a contingent right to receive one Medpace common share. They also state that 113 restricted stock units were granted on November 28, 2025, vesting in four approximately equal installments during 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
